GB9618967D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9618967D0
GB9618967D0 GBGB9618967.5A GB9618967A GB9618967D0 GB 9618967 D0 GB9618967 D0 GB 9618967D0 GB 9618967 A GB9618967 A GB 9618967A GB 9618967 D0 GB9618967 D0 GB 9618967D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9618967.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9618967.5A priority Critical patent/GB9618967D0/en
Publication of GB9618967D0 publication Critical patent/GB9618967D0/en
Priority to CO97051291A priority patent/CO4930263A1/en
Priority to AT97910322T priority patent/ATE358121T1/en
Priority to EP97910322A priority patent/EP0927163B1/en
Priority to SI9730763T priority patent/SI0927163T1/en
Priority to BR9712014A priority patent/BR9712014A/en
Priority to TR1999/00493T priority patent/TR199900493T2/en
Priority to CA002266468A priority patent/CA2266468C/en
Priority to DE69737529T priority patent/DE69737529T2/en
Priority to ARP970104108A priority patent/AR008174A1/en
Priority to CN97197756A priority patent/CN1102927C/en
Priority to NZ334272A priority patent/NZ334272A/en
Priority to PT97910322T priority patent/PT927163E/en
Priority to JP51328398A priority patent/JP3748570B2/en
Priority to CZ1999809A priority patent/CZ290932B6/en
Priority to HU9904155A priority patent/HUP9904155A3/en
Priority to IL12878597A priority patent/IL128785A0/en
Priority to PL332088A priority patent/PL191373B1/en
Priority to DK97910322T priority patent/DK0927163T3/en
Priority to AU47764/97A priority patent/AU725210B2/en
Priority to PCT/EP1997/005167 priority patent/WO1998011067A1/en
Priority to KR10-1999-7001990A priority patent/KR100525703B1/en
Priority to ZA978087A priority patent/ZA978087B/en
Priority to ES97910322T priority patent/ES2285732T3/en
Priority to SA97180387A priority patent/SA97180387B1/en
Priority to TW086113072A priority patent/TW432048B/en
Priority to NO19991148A priority patent/NO312587B1/en
Priority to HK00100041A priority patent/HK1020963A1/en
Priority to US09/643,644 priority patent/US6331631B1/en
Priority to JP2004380260A priority patent/JP2005220126A/en
Priority to CY0800005A priority patent/CY2590B2/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Optical Couplings Of Light Guides (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GBGB9618967.5A 1996-09-11 1996-09-11 Pharmaceuticals Pending GB9618967D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB9618967.5A GB9618967D0 (en) 1996-09-11 1996-09-11 Pharmaceuticals
CO97051291A CO4930263A1 (en) 1996-09-11 1997-09-04 PROCESS FOR THE PREPARATION OF 4-PIPERIDINYL METHYLAMINE.
ES97910322T ES2285732T3 (en) 1996-09-11 1997-09-09 PREPARATION OF 1-BUTIL-4-PIPERIDINYLMETILAMINE.
CZ1999809A CZ290932B6 (en) 1996-09-11 1997-09-09 Process for preparing 1-butyl-4-piperidyl methylamine
PL332088A PL191373B1 (en) 1996-09-11 1997-09-09 Production of 1-butyl-4-piperidinylmethylamine
SI9730763T SI0927163T1 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
BR9712014A BR9712014A (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinyl methyl amine
TR1999/00493T TR199900493T2 (en) 1996-09-11 1997-09-09 1-Butyl-4-Piperidinilmetilamine is a hazrlanmas�.
CA002266468A CA2266468C (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
DE69737529T DE69737529T2 (en) 1996-09-11 1997-09-09 Preparation of 1-Butyl-4-piperidin-methylmethylamine
ARP970104108A AR008174A1 (en) 1996-09-11 1997-09-09 A PROCEDURE TO PREPARE 1-BUTYL-4-PIPERIDINMETILAMINA
CN97197756A CN1102927C (en) 1996-09-11 1997-09-09 Prepn. of 1-butyl-4-piperidinylmethylamine
NZ334272A NZ334272A (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine using toulene as a solvent which is used to prepare N-[(1-n-butyl-4-piperidyl methyl]-3,4-dihydro-2H[1,3]oxazino[3,2-a]indole-10-carboxamide
PT97910322T PT927163E (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
JP51328398A JP3748570B2 (en) 1996-09-11 1997-09-09 Production of 1-butyl-4-piperidinylmethylamine
AT97910322T ATE358121T1 (en) 1996-09-11 1997-09-09 PRODUCTION OF 1-BUTYL-4-PIPERIDINYL METHYLAMIN
HU9904155A HUP9904155A3 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
IL12878597A IL128785A0 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
EP97910322A EP0927163B1 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
DK97910322T DK0927163T3 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
AU47764/97A AU725210B2 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
PCT/EP1997/005167 WO1998011067A1 (en) 1996-09-11 1997-09-09 Preparation of 1-butyl-4-piperidinylmethylamine
KR10-1999-7001990A KR100525703B1 (en) 1996-09-11 1997-09-09 Preparation of 1-Butyl-4-piperidinylmethylamine
ZA978087A ZA978087B (en) 1996-09-11 1997-09-09 Pharmaceuticals
TW086113072A TW432048B (en) 1996-09-11 1997-09-10 Processes for the preparation of 1-butyl-4-piperidinylmethylamine and N-[(1-n-butyl-4-piperidyl) methyl]-3,4-dihydro-2H-[1,3] oxazino [3,2-a] indole-10-carboxamide
SA97180387A SA97180387B1 (en) 1996-09-11 1997-09-10 Process for the preparation of -butyl-4- piperidinylmethylamine
NO19991148A NO312587B1 (en) 1996-09-11 1999-03-10 Process for the preparation of 1-butyl-4-piperidinylmethylamine
HK00100041A HK1020963A1 (en) 1996-09-11 2000-01-04 Preparation of 1-butyl-4-piperidinylmethylamine
US09/643,644 US6331631B1 (en) 1996-09-11 2000-08-22 Preparation of 1-butyl-4-piperidinylmethylamine
JP2004380260A JP2005220126A (en) 1996-09-11 2004-12-28 Method for producing 1-butyl-4-piperidinylmethylamine
CY0800005A CY2590B2 (en) 1996-09-11 2008-02-29 Preparation of 1-butyl-4-piperidinylmethylamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9618967.5A GB9618967D0 (en) 1996-09-11 1996-09-11 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9618967D0 true GB9618967D0 (en) 1996-10-23

Family

ID=10799764

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9618967.5A Pending GB9618967D0 (en) 1996-09-11 1996-09-11 Pharmaceuticals

Country Status (30)

Country Link
US (1) US6331631B1 (en)
EP (1) EP0927163B1 (en)
JP (2) JP3748570B2 (en)
KR (1) KR100525703B1 (en)
CN (1) CN1102927C (en)
AR (1) AR008174A1 (en)
AT (1) ATE358121T1 (en)
AU (1) AU725210B2 (en)
BR (1) BR9712014A (en)
CA (1) CA2266468C (en)
CO (1) CO4930263A1 (en)
CY (1) CY2590B2 (en)
CZ (1) CZ290932B6 (en)
DE (1) DE69737529T2 (en)
DK (1) DK0927163T3 (en)
ES (1) ES2285732T3 (en)
GB (1) GB9618967D0 (en)
HK (1) HK1020963A1 (en)
HU (1) HUP9904155A3 (en)
IL (1) IL128785A0 (en)
NO (1) NO312587B1 (en)
NZ (1) NZ334272A (en)
PL (1) PL191373B1 (en)
PT (1) PT927163E (en)
SA (1) SA97180387B1 (en)
SI (1) SI0927163T1 (en)
TR (1) TR199900493T2 (en)
TW (1) TW432048B (en)
WO (1) WO1998011067A1 (en)
ZA (1) ZA978087B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals
US20020091271A1 (en) 1998-07-16 2002-07-11 Smithkline Beecham Plc Process for the preparation of an indole derivative
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
CN104557672B (en) * 2015-01-26 2016-09-21 湖南华腾制药有限公司 A kind of preparation method of 1 substituted piperidine derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821904B2 (en) * 1975-04-04 1983-05-04 住友化学工業株式会社 Sinkinamethano-anthracene
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
AT394715B (en) * 1990-08-14 1992-06-10 Chemie Linz Gmbh METHOD FOR N-ALKYLATING UREAS
ATE182591T1 (en) * 1991-09-12 1999-08-15 Smithkline Beecham Plc 5-HT4 RECEPTOR ANTAGONISTS
MA22647A1 (en) * 1991-09-14 1993-04-01 Smithkline Beecham Plc PROCESS FOR THE PREPARATION OF AN ESTER OR AMIDE OF A NEW PRODUCT.
EP0884319B1 (en) * 1992-03-12 2004-05-06 SmithKline Beecham plc N- (1-nButyl-4-piperidyl)methyl -3,4-dihydro-2H- 1,3 oxazino 3,2-a indole-10-carboxamide or a pharmaceutically acceptable salt thereof
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
EP0664794A1 (en) * 1992-10-16 1995-08-02 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
DE4427836A1 (en) * 1994-08-05 1996-02-08 Hoechst Ag Compounds from the range of phosphines, processes for their preparation and their use
DE69627323T2 (en) * 1995-05-31 2004-01-15 Nisshin Seifun Group Inc INDAZOLE DERIVATIVES WITH A CYCLIC AMINO GROUP
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
CN1102927C (en) 2003-03-12
HUP9904155A3 (en) 2001-01-29
CY2590B2 (en) 2009-11-04
AR008174A1 (en) 1999-12-09
DK0927163T3 (en) 2007-08-06
KR100525703B1 (en) 2005-11-03
PL332088A1 (en) 1999-08-30
DE69737529T2 (en) 2008-01-31
EP0927163B1 (en) 2007-03-28
NO991148L (en) 1999-03-10
CA2266468C (en) 2005-10-25
HUP9904155A2 (en) 2000-05-28
JP2005220126A (en) 2005-08-18
KR20000038041A (en) 2000-07-05
BR9712014A (en) 1999-08-24
CN1230179A (en) 1999-09-29
NO991148D0 (en) 1999-03-10
CA2266468A1 (en) 1998-03-19
TR199900493T2 (en) 1999-06-21
PT927163E (en) 2007-07-06
ES2285732T3 (en) 2007-11-16
CO4930263A1 (en) 2000-06-27
EP0927163A1 (en) 1999-07-07
PL191373B1 (en) 2006-05-31
SA97180387B1 (en) 2006-11-04
AU725210B2 (en) 2000-10-05
NZ334272A (en) 2000-08-25
ATE358121T1 (en) 2007-04-15
HK1020963A1 (en) 2000-05-26
DE69737529D1 (en) 2007-05-10
NO312587B1 (en) 2002-06-03
TW432048B (en) 2001-05-01
SI0927163T1 (en) 2007-08-31
JP3748570B2 (en) 2006-02-22
CZ80999A3 (en) 1999-11-17
CZ290932B6 (en) 2002-11-13
US6331631B1 (en) 2001-12-18
IL128785A0 (en) 2000-01-31
WO1998011067A1 (en) 1998-03-19
ZA978087B (en) 1999-03-09
AU4776497A (en) 1998-04-02
JP2001500148A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
GB9615202D0 (en) Pharmaceuticals
GB9601544D0 (en) Pharmaceuticals
EG23684A (en) Pharmaceuticals
GB9618967D0 (en) Pharmaceuticals
GB9606745D0 (en) Pharmaceuticals
GB9606414D0 (en) Pharmaceuticals
GB9615273D0 (en) Pharmaceuticals
GB9606636D0 (en) Pharmaceuticals
GB9615253D0 (en) Pharmaceuticals
GB9615272D0 (en) Pharmaceuticals
GB9604909D0 (en) Pharmaceuticals
GB9604671D0 (en) Pharmaceuticals
GB9604453D0 (en) Pharmaceuticals
GB9604447D0 (en) Pharmaceuticals
GB9602403D0 (en) Pharmaceuticals
GB9602133D0 (en) Pharmaceuticals
GB9602132D0 (en) Pharmaceuticals
GB9601546D0 (en) Pharmaceuticals
GB9606766D0 (en) Pharmaceuticals
GB9607132D0 (en) Pharmaceuticals
GB9607870D0 (en) Pharmaceuticals
GB9610906D0 (en) Pharmaceuticals
GB9614115D0 (en) Pharmaceuticals
GB9615111D0 (en) Pharmaceuticals
GB9610909D0 (en) Pharmaceuticals